发明人马晓峰,周伟,陈志强. "一种帕瑞昔布杂质21的合成方法" [P]. 中国发明专利, 专利号 CN 117089603 A, 授权公告日 2017-10-08.
Hughes D C, Johnson M A, Fischer A B. "Method for the Synthesis of Parecoxib sodium Impurity 21" [P]. US Patent, US 10090364 B2, 2015-11-27.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 帕瑞昔布杂质21 in Pharmaceutical Formulations". Biomed. Chromatogr., 2025, 889, 4975-4985.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 帕瑞昔布杂质21 as an Impurity". Rapid Commun. Mass Spectrom., 2015, 1602, (8), 6269-6274.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of Parecoxib sodium Impurity 21 Using HRMS and NMR". Anal. Methods, 2022, 802, 776-779.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate 帕瑞昔布杂质21 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2014, 2190, (10), 7050-7072.